Literature DB >> 12682550

Incidence and prognostic value of positive peritoneal cytology in colorectal cancer.

I Kanellos1, H Demetriades, E Zintzaras, A Mandrali, I Mantzoros, D Betsis.   

Abstract

PURPOSE: This study was conducted to investigate the incidence of free cancer cells in the peritoneal washings of patients who had undergone surgery for colorectal cancer and to evaluate its influence as a prognostic factor of the disease.
METHODS: From 1990 to 1996, intraoperative washing cytology was performed in 110 patients who underwent surgery for colorectal cancer. All patients had curative resections. Immediately after the abdomen was opened and before exploration and mobilization of the tumor, 100 ml of saline was injected over the tumor site. Washings were then aspirated and taken for cytologic examination.
RESULTS: Twenty-two (20 percent) of 110 patients examined were found to have positive cytology for intraperitoneal free malignant cells. The site of tumor in the colon or rectum, tumor size, nodal status, degree of differentiation, mucinous characteristics, and vascular or neural invasion were found not to affect the incidence of free cancer cells. Conversely, tumor penetration was found to affect the incidence of positive cytology. The degree of association among the stages of tumor penetration was indicated by the contingency coefficient, which was 0.42. Patients with positive cytology had a significantly higher rate of local recurrence and peritoneal carcinomatosis (22.8 vs. 8 percent, P = 0.05) than patients with negative cytology. Mortality rate was not found to be related to the presence of free cancer cells.
CONCLUSION: Cytologic examination of peritoneal lavage at the time of surgery could be a useful prognostic indicator for local and peritoneal recurrence rate. However, it was not found to be a predictor of survival.

Entities:  

Mesh:

Year:  2003        PMID: 12682550     DOI: 10.1007/s10350-004-6595-0

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  21 in total

Review 1.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

Review 2.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer.

Authors:  Yoichiro Homma; Takashi Hamano; Yasuhiro Akazawa; Yoshiro Otsuki; Shinichi Shimizu; Hiroshi Kobayashi; Shingo Kameoka; Yasuyuki Kobayashi
Journal:  Surg Today       Date:  2013-08-14       Impact factor: 2.549

4.  Prognostic significance of peritoneal lavage cytology in patients with colorectal cancer.

Authors:  Hirotoshi Kobayashi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2012-02-28       Impact factor: 3.402

5.  Impact of positive intraabdominal lavage cytology on the long-term prognosis of colorectal cancer patients.

Authors:  Rita Temesi; László Sikorszki; János Bezsilla; Akos Botos; Judit Kovács; Tibor Tihanyi
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

6.  Water lavage as an adjunct to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).

Authors:  Emmanuel Gabriel; Smit Singla; Minhyung Kim; Daniel Fisher; Colin Powers; Anthony Visioni; Kristopher Attwood; Joseph Skitzki
Journal:  Am J Surg       Date:  2017-06-06       Impact factor: 2.565

Review 7.  Intra-operative peritoneal lavage for colorectal cancer.

Authors:  Guillaume Passot; Kayvan Mohkam; Eddy Cotte; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models.

Authors:  Yi-Yu Lin; Chih-Hsien Chang; Jia-Je Li; Michael G Stabin; Ya-Jen Chang; Liang-Cheng Chen; Ming-Hsien Lin; Yun-Long Tseng; Wuu-Jyh Lin; Te-Wei Lee; Gann Ting; Cheng Allen Chang; Fu-Du Chen; Hsin-Ell Wang
Journal:  Cancer Biother Radiopharm       Date:  2011-06-28       Impact factor: 3.099

9.  Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study.

Authors:  Byung Chul Kim; Jung Hoon Bae; Sun Min Park; Dae Youn Won; In Kyu Lee
Journal:  Int J Colorectal Dis       Date:  2019-12-05       Impact factor: 2.571

10.  Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer.

Authors:  Masayasu Hara; Hayao Nakanishi; Qian Jun; Yukihide Kanemitsu; Seiji Ito; Yoshinari Mochizuki; Yoshitaka Yamamura; Yasuhiro Kodera; Masae Tatematsu; Takashi Hirai; Tomoyuki Kato
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.